Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.

Obinata H, Kuo A, Wada Y, Swendeman S, Liu CH, Blaho VA, Nagumo R, Sato K, Izumi T, Hla T.

J Lipid Res. 2019 Aug 28. pii: jlr.RA119000277. doi: 10.1194/jlr.RA119000277. [Epub ahead of print]

2.

Lipid Mediators, M2 Macrophages, and Pathological Neovascularization.

Swendeman SL, Hla T.

Trends Mol Med. 2018 Dec;24(12):977-978. doi: 10.1016/j.molmed.2018.10.003. Epub 2018 Nov 15.

PMID:
30448396
3.

Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.

Burg N, Swendeman S, Worgall S, Hla T, Salmon JE.

Arthritis Rheumatol. 2018 Nov;70(11):1879-1889. doi: 10.1002/art.40558.

PMID:
29781582
4.

An engineered S1P chaperone attenuates hypertension and ischemic injury.

Swendeman SL, Xiong Y, Cantalupo A, Yuan H, Burg N, Hisano Y, Cartier A, Liu CH, Engelbrecht E, Blaho V, Zhang Y, Yanagida K, Galvani S, Obinata H, Salmon JE, Sanchez T, Di Lorenzo A, Hla T.

Sci Signal. 2017 Aug 15;10(492). pii: eaal2722. doi: 10.1126/scisignal.aal2722.

5.

Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays.

Maretzky T, Swendeman S, Mogollon E, Weskamp G, Sahin U, Reiss K, Blobel CP.

Biochem J. 2017 Apr 13;474(9):1467-1479. doi: 10.1042/BCJ20170075.

PMID:
28264989
6.

HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver.

Ding BS, Liu CH, Sun Y, Chen Y, Swendeman SL, Jung B, Chavez D, Cao Z, Christoffersen C, Nielsen LB, Schwab SR, Rafii S, Hla T.

JCI Insight. 2016 Dec 22;1(21):e87058. doi: 10.1172/jci.insight.87058.

7.

Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.

Christensen PM, Liu CH, Swendeman SL, Obinata H, Qvortrup K, Nielsen LB, Hla T, Di Lorenzo A, Christoffersen C.

FASEB J. 2016 Jun;30(6):2351-9. doi: 10.1096/fj.201500064. Epub 2016 Mar 8.

8.

HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.

Galvani S, Sanson M, Blaho VA, Swendeman SL, Obinata H, Conger H, Dahlbäck B, Kono M, Proia RL, Smith JD, Hla T.

Sci Signal. 2015 Aug 11;8(389):ra79. doi: 10.1126/scisignal.aaa2581. Erratum in: Sci Signal. 2015 Oct 27;8(400):er8. Obinata, Hideru [added].

9.

HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.

Blaho VA, Galvani S, Engelbrecht E, Liu C, Swendeman SL, Kono M, Proia RL, Steinman L, Han MH, Hla T.

Nature. 2015 Jul 16;523(7560):342-6. doi: 10.1038/nature14462. Epub 2015 Jun 8.

10.

iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.

Issuree PD, Maretzky T, McIlwain DR, Monette S, Qing X, Lang PA, Swendeman SL, Park-Min KH, Binder N, Kalliolias GD, Yarilina A, Horiuchi K, Ivashkiv LB, Mak TW, Salmon JE, Blobel CP.

J Clin Invest. 2013 Feb;123(2):928-32. doi: 10.1172/JCI66168. Epub 2013 Jan 25.

11.

Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice.

Hewing NJ, Weskamp G, Vermaat J, Farage E, Glomski K, Swendeman S, Chan RV, Chiang MF, Khokha R, Anand-Apte B, Blobel CP.

Invest Ophthalmol Vis Sci. 2013 Jan 30;54(1):864-70. doi: 10.1167/iovs.12-10954.

12.

Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.

Maretzky T, Evers A, Zhou W, Swendeman SL, Wong PM, Rafii S, Reiss K, Blobel CP.

Nat Commun. 2011;2:229. doi: 10.1038/ncomms1232.

13.
14.

ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.

Guaiquil VH, Swendeman S, Zhou W, Guaiquil P, Weskamp G, Bartsch JW, Blobel CP.

J Mol Med (Berl). 2010 May;88(5):497-505. doi: 10.1007/s00109-010-0591-8. Epub 2010 Jan 30.

15.

Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.

Weskamp G, Mendelson K, Swendeman S, Le Gall S, Ma Y, Lyman S, Hinoki A, Eguchi S, Guaiquil V, Horiuchi K, Blobel CP.

Circ Res. 2010 Mar 19;106(5):932-40. doi: 10.1161/CIRCRESAHA.109.207415. Epub 2010 Jan 28.

16.

Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice.

Parry DA, Toomes C, Bida L, Danciger M, Towns KV, McKibbin M, Jacobson SG, Logan CV, Ali M, Bond J, Chance R, Swendeman S, Daniele LL, Springell K, Adams M, Johnson CA, Booth AP, Jafri H, Rashid Y, Banin E, Strom TM, Farber DB, Sharon D, Blobel CP, Pugh EN Jr, Pierce EA, Inglehearn CF.

Am J Hum Genet. 2009 May;84(5):683-91. doi: 10.1016/j.ajhg.2009.04.005. Epub 2009 Apr 30.

17.

ADAM9 is involved in pathological retinal neovascularization.

Guaiquil V, Swendeman S, Yoshida T, Chavala S, Campochiaro PA, Blobel CP.

Mol Cell Biol. 2009 May;29(10):2694-703. doi: 10.1128/MCB.01460-08. Epub 2009 Mar 9.

18.

VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.

Swendeman S, Mendelson K, Weskamp G, Horiuchi K, Deutsch U, Scherle P, Hooper A, Rafii S, Blobel CP.

Circ Res. 2008 Oct 24;103(9):916-8. doi: 10.1161/CIRCRESAHA.108.184416. Epub 2008 Sep 25.

19.

ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.

Weskamp G, Ford JW, Sturgill J, Martin S, Docherty AJ, Swendeman S, Broadway N, Hartmann D, Saftig P, Umland S, Sehara-Fujisawa A, Black RA, Ludwig A, Becherer JD, Conrad DH, Blobel CP.

Nat Immunol. 2006 Dec;7(12):1293-8. Epub 2006 Oct 29.

PMID:
17072319
20.

A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival.

Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL.

Blood. 2005 Jun 1;105(11):4429-36. Epub 2005 Jan 18.

PMID:
15657181
21.

Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.

Coffey DC, Kutko MC, Glick RD, Swendeman SL, Butler L, Rifkind R, Marks PA, Richon VM, LaQuaglia MP.

Med Pediatr Oncol. 2000 Dec;35(6):577-81.

PMID:
11107121
22.

Identification and characterization of a critical CP2-binding element in the human interleukin-4 promoter.

Casolaro V, Keane-Myers AM, Swendeman SL, Steindler C, Zhong F, Sheffery M, Georas SN, Ono SJ.

J Biol Chem. 2000 Nov 24;275(47):36605-11.

23.

The effects of serum depletion and dexamethasone on growth and differentiation of human neuroblastoma cell lines.

Glick RD, Medary I, Aronson DC, Scotto KW, Swendeman SL, La Quaglia MP.

J Pediatr Surg. 2000 Mar;35(3):465-72.

PMID:
10726691
24.

Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.

Glick RD, Swendeman SL, Coffey DC, Rifkind RA, Marks PA, Richon VM, La Quaglia MP.

Cancer Res. 1999 Sep 1;59(17):4392-9.

25.
26.

Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.

Kovalev S, Marchenko N, Swendeman S, LaQuaglia M, Moll UM.

Cell Growth Differ. 1998 Nov;9(11):897-903.

27.

cDNA subtraction hybridization: a review and an application to neuroblastoma.

Swendeman SL, La Quaglia MP.

Semin Pediatr Surg. 1996 Aug;5(3):149-54. Review.

PMID:
8858760
29.

Characterization of the genomic structure, chromosomal location, promoter, and development expression of the alpha-globin transcription factor CP2.

Swendeman SL, Spielholz C, Jenkins NA, Gilbert DJ, Copeland NG, Sheffery M.

J Biol Chem. 1994 Apr 15;269(15):11663-71.

30.

Characterization of the molecularly cloned murine alpha-globin transcription factor CP2.

Lim LC, Fang L, Swendeman SL, Sheffery M.

J Biol Chem. 1993 Aug 25;268(24):18008-17.

31.

Molecular cloning of the alpha-globin transcription factor CP2.

Lim LC, Swendeman SL, Sheffery M.

Mol Cell Biol. 1992 Feb;12(2):828-35.

32.

Promoter elements and erythroid cell nuclear factors that regulate alpha-globin gene transcription in vitro.

Kim CG, Swendeman SL, Barnhart KM, Sheffery M.

Mol Cell Biol. 1990 Nov;10(11):5958-66.

33.

Soluble CD23/BLAST-2 (S-CD23/Blast-2) and its role in B cell proliferation.

Swendeman SL, Thorley-Lawson D.

Curr Top Microbiol Immunol. 1988;141:157-64. No abstract available.

PMID:
2975205
34.
35.

Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens.

Thorley-Lawson DA, Swendeman SL, Edson CM.

J Immunol. 1986 Mar 1;136(5):1745-51.

PMID:
3081632

Supplemental Content

Loading ...
Support Center